Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

NCT00004055 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: paclitaxel
DRUG: topotecan hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]